PEDIATRICS

Optimize study design for pediatric patients.

Improve study outcomes for pediatric therapies by addressing the needs of children and their families –
from formulations to biospecimen requirements.

Expertise from start to finish

Pediatric expertise is essential to developing and commercializing pediatric therapies, from the earliest planning stages through launch and real-world assessment. We provide a range of scientific, therapeutic, regulatory, and operational expertise to ensure study success.

These resources extend beyond IQVIA to encompass a global network of top performing sites, ensuring there are sites around the world with the proven ability to conduct every pediatric trial.

Experienced team and trusted networks

  • IQVIA’s medical, R&D, and operational teams offer expertise across multiple therapeutic areas.
  • Pediatric and Rare Disease Network accelerates enrollment and promotes collaboration among sites in multiple regions.
  • Navigate regulatory requirements by age and country and collaborate on protocol writing.
  • Pediatric Early Phase Oncology Network develops KOL and PI relationships at high-performing sites about study feasibility, design, start-up, and more.
  • Innovative direct to patient recruiting approaches, including digital, capitalize on social listening and community outreach.

Understanding of patient and family needs

Successful pediatric trial designs are attentive to the needs of infant, child, or adolescent patients. And decision making about study participation typically involves multiple family members.

IQVIA considers the differences within pediatric sub-populations and takes a sensitive approach to these patients and their caregivers.

Intelligent study design speeds execution

  • Conceptualize program and study design including use of modeling and simulation.
  • Integrate Real World Evidence and patient registries to enable external comparators.
  • Extensive implementation experience to customize and deliver your pediatric trial.
  • Recognize pre-symptomatic disease presentation and identify patients faster using AI/ML.
  • Develop and submit PIPs and PSPs to ensure vital clinical data collection.

Solutions you may be interested in

Contact Us